| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 134.49B | 129.99B | 127.98B | 124.01B | 113.31B |
| Gross Profit | 44.22B | 38.81B | 37.98B | 39.59B | 38.57B |
| EBITDA | 8.71B | 7.47B | 5.61B | 6.24B | 6.84B |
| Net Income | 3.48B | 1.72B | 1.47B | 2.52B | 3.15B |
Balance Sheet | |||||
| Total Assets | 93.44B | 90.48B | 91.19B | 87.94B | 85.29B |
| Cash, Cash Equivalents and Short-Term Investments | 19.38B | 19.23B | 19.07B | 22.53B | 22.78B |
| Total Debt | 8.76B | 7.18B | 5.76B | 4.55B | 5.29B |
| Total Liabilities | 32.99B | 33.38B | 34.52B | 32.08B | 30.65B |
| Stockholders Equity | 60.44B | 57.10B | 56.67B | 55.86B | 54.64B |
Cash Flow | |||||
| Free Cash Flow | 2.06B | 1.06B | -1.18B | 2.63B | 4.09B |
| Operating Cash Flow | 4.18B | 4.35B | 2.43B | 4.30B | 5.78B |
| Investing Cash Flow | -2.86B | -4.50B | -5.36B | -2.29B | -2.62B |
| Financing Cash Flow | -750.00M | 251.00M | -572.00M | -2.02B | -3.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥187.69B | 12.48 | ― | 3.41% | 3.85% | 42.23% | |
73 Outperform | ¥31.66B | 9.00 | ― | 3.56% | 3.46% | 102.90% | |
73 Outperform | ¥478.60B | 13.15 | 8.51% | 2.25% | 2.19% | 23.96% | |
73 Outperform | ¥169.09B | 11.58 | ― | 4.91% | 3.03% | 16.46% | |
67 Neutral | ¥66.43B | 27.88 | 1.61% | 2.27% | 0.39% | -21.22% | |
67 Neutral | ¥18.75B | 8.43 | ― | 3.46% | 4.11% | 3.43% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |